We are live on ! Find out more
KRRO icon

Korro Bio

83 hedge funds and large institutions have $60.6M invested in Korro Bio in 2025 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 24 increasing their positions, 22 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

9% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 22

10% less funds holding

Funds holding: 9283 (-9)

23.68% less ownership

Funds ownership: 103.97%80.3% (-24%)

27% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 30

87% less capital invested

Capital invested by funds: $466M → $60.6M (-$405M)

98% less call options, than puts

Call options by funds: $163K | Put options by funds: $7.93M

Holders
83
Holders Change
-9
Holders Change %
-9.78%
% of All Funds
1.01%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
22
Increased
24
Reduced
22
Closed
30
Calls
$163K
Puts
$7.93M
Net Calls
-$7.77M
Net Calls Change
-$7.77M
Name Holding Trade Value Shares
Change
Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$9.11M
NMC
2
NEA Management Company
Maryland
$8.74M
LCM
3
Lynx1 Capital Management
Puerto Rico
$5.43M +$15.8M +677,915 New
NCM
4
Nantahala Capital Management
Connecticut
$4.81M +$14M +600,000 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$3.92M +$2.2M +93,980 +24%
BlackRock
6
BlackRock
New York
$3.66M +$250K +10,701 +2%
TCM
7
TCG Crossover Management
California
$3.33M
SL
8
Siren LLC
Connecticut
$2.79M -$1.66M -71,115 -17%
Jane Street
9
Jane Street
New York
$2.31M +$6.74M +288,457 New
7IH
10
72 Investment Holdings
Connecticut
$2.22M
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
$1.58M +$4.6M +196,827 New
Geode Capital Management
12
Geode Capital Management
Massachusetts
$1.3M -$4.02K -172 -0.1%
Millennium Management
13
Millennium Management
New York
$1.29M -$2.32M -99,241 -38%
State Street
14
State Street
Massachusetts
$1.17M +$506K +21,652 +17%
Two Sigma Investments
15
Two Sigma Investments
New York
$633K +$340K +14,529 +23%
Renaissance Technologies
16
Renaissance Technologies
New York
$600K +$806K +34,500 +85%
Morgan Stanley
17
Morgan Stanley
New York
$559K -$2.29M -97,766 -58%
EMFAT
18
Emerald Mutual Fund Advisers Trust
Pennsylvania
$525K +$155K +6,637 +11%
FMI
19
F/M Investments
District of Columbia
$525K +$241K +10,303 +19%
Citadel Advisors
20
Citadel Advisors
Florida
$467K -$2.23M -95,599 -62%
XT
21
XTX Topco
Cayman Islands
$457K +$316K +13,529 +31%
Northern Trust
22
Northern Trust
Illinois
$446K -$38.2K -1,633 -3%
Goldman Sachs
23
Goldman Sachs
New York
$416K +$848K +36,269 +231%
GCM
24
Graham Capital Management
Connecticut
$327K +$953K +40,766 New
AQR Capital Management
25
AQR Capital Management
Connecticut
$326K -$181K -7,760 -16%

KRRO Hedge Fund Activity: Q4 2025 in Review

83 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q4 2025, worth a combined $60.6M — down 87% from $466M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of KRRO and 22 opened new positions — a net loss of 8 holders — while 22 trimmed existing stakes and 24 added.

The largest buyer was Lynx1 Capital Management, opening a new position worth an estimated $15.8M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $32.2M sold.

  • 83 institutional investors held Korro Bio (KRRO) as of Q4 2025, down from 92 in Q3 2025.
  • Funds reported $60.6M of Korro Bio stock for Q4 2025, down 87% quarter-over-quarter.
  • 22 funds opened new Korro Bio positions in Q4 2025 and 30 closed out, a net change of -8 holders.
  • The largest Korro Bio buyer in Q4 2025 was Lynx1 Capital Management, an estimated $15.8M added.
  • The largest Korro Bio seller in Q4 2025 was Driehaus Capital Management, an estimated $32.2M sold.

Based on aggregated 13F filings for Q4 2025.